Immatics N.V. (IMTX) Financials

IMTX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 463.1 million 200.8 million
2023-06-30 446.0 million 208.7 million
2023-03-31 412.6 million 194.5 million
2022-12-31 437.7 million 208.9 million

IMTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -39.2 million 5.0 million
2023-06-30 -19.0 million 6.0 million
2023-03-31 -30.6 million 6.7 million
2022-12-31 -36.5 million 6.3 million

IMTX Net Income

No data available :(

IMTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 387.5 million - 17.4 million
2023-06-30 378.0 million - 18.3 million
2023-03-31 359.5 million - 16.3 million
2022-12-31 388.7 million - 15.6 million

IMTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 88.3 million
2023-06-30 84.1 million
2023-03-31 83.6 million
2022-12-31 73.2 million

IMTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 6.9 million 32.3 million 9.4 million -
2023-06-30 11.8 million 29.7 million 7.4 million -
2023-03-31 4.7 million 30.1 million 10.4 million -
2022-12-31 2.8 million 29.9 million 10.5 million -

IMTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 6.3 million -
2023-06-30 24.3 million 29.7 million
2023-03-31 10.7 million 30.1 million
2022-12-31 40.4 million 29.9 million

IMTX

Price: $10.77

52 week price:
5.90
13.16

Earnings Per Share: -1.22 USD

P/E Ratio: -9.17

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 207152

Market Capitalization: 1.2 billion

Links: